ArticleBlood neoplasia2024
Ibrutinib and venetoclax in combination for chronic lymphocytic leukemia: synergy in practice.
Natalia Timofeeva et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
8 papers cite it
this paperpooled ittrialcites it